Demographic and Social Patterns of the Mean Values of Inflammatory Markers in U.S. Adults: A 2009–2016 NHANES Analysis
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Mean Inflammatory Marker Values in U.S. Adults
3.2. Univariate Associations of Demographic Factors and Inflammatory Markers
3.3. Multivariable Regression Results for Inflammatory Markers
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bhat, T.; Teli, S.; Rijal, J.; Bhat, H.; Raza, M.; Khoueiry, G.; Meghani, M.; Akhtar, M. Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev. Cardiovasc. Ther. 2013, 11, 55–59. [Google Scholar] [CrossRef] [PubMed]
- Turkmen, K.; Guney, I.; Yerlikaya, F.H.; Tonbul, H.Z. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren. Fail. 2012, 34, 155–159. [Google Scholar] [CrossRef] [PubMed]
- Cedrés, S.; Torrejon, D.; Martínez, A.; Martinez, P.; Navarro, A.; Zamora, E.; Mulet-Margalef, N. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin. Transl. Oncol. 2012, 14, 864–869. [Google Scholar] [CrossRef] [PubMed]
- An, X.; Ding, P.R.; Li, Y.H.; Wang, F.-H.; Shi, Y.-X.; Wang, Z.-Q.; He, Y.-J.; Xu, R.-H. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 2010, 15, 516–522. [Google Scholar] [CrossRef] [PubMed]
- Walsh, S.R.; Cook, E.J.; Goulder, F.; Justin, T.A.; Keeling, N.J. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J. Surg. Oncol. 2005, 91, 181–184. [Google Scholar] [CrossRef]
- Cho, H.; Hur, H.W.; Kim, S.W.; Kim, S.H.; Kim, J.H.; Kim, Y.T.; Lee, K. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol. Immunother. 2009, 58, 15–23. [Google Scholar] [CrossRef]
- Sun, X.; Xue, Z.; Yasin, A.; He, Y.; Chai, Y.; Li, J.; Zhang, K. Colorectal Cancer and Adjacent Normal Mucosa Differ in Apoptotic and Inflammatory Protein Expression. Eng. Regen. 2022, 2, 279–287. [Google Scholar] [CrossRef]
- Guthrie, G.J.; Charles, K.A.; Roxburgh, C.S.; Horgan, P.G.; McMillan, D.C.; Clarke, S.J. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit. Rev. Oncol. Hematol. 2013, 88, 218–230. [Google Scholar] [CrossRef]
- Proctor, M.J.; Morrison, D.S.; Talwar, D.; Balmer, S.M.; Fletcher, C.D.; O’Reilly, D.S.J.; Foulis, A.K.; Horgan, P.G.; McMillan, D.C. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur. J. Cancer 2011, 47, 2633–2641. [Google Scholar] [CrossRef]
- Farah, R.; Ibrahim, R.; Nassar, M.; Najib, D.; Zivony, Y.; Eshel, E. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Panminerva Med. 2017, 59, 203–209. [Google Scholar] [CrossRef]
- Azab, B.; Bhatt, V.R.; Phookan, J.; Murukutla, S.; Kohn, N.; Terjanian, T.; Widmann, W.D. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann. Surg. Oncol. 2012, 19, 217–224. [Google Scholar] [CrossRef] [PubMed]
- Núñez, J.; Núñez, E.; Bodí, V.; Sanchis, J.; Miñana, G.; Mainar, L.; Santas, E.; Merlos, P.; Rumiz, E.; Darmofal, H.; et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am. J. Cardiol. 2008, 101, 747–752. [Google Scholar] [CrossRef] [PubMed]
- Durmus, E.; Kivrak, T.; Gerin, F.; Sunbul, M.; Sari, I.; Erdogan, O. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Arq. Bras. Cardiol. 2015, 105, 606–613. [Google Scholar] [CrossRef] [PubMed]
- Xu, Z.; Xu, W.; Cheng, H.; Shen, W.; Ying, J.; Cheng, F.; Xu, W. The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis. PLoS ONE 2016, 11, e0163719. [Google Scholar] [CrossRef] [PubMed]
- Gu, X.; Gao, X.S.; Qin, S.; Li, X.; Qi, X.; Ma, M.; Yu, H.; Sun, S.; Zhou, D.; Wang, W.; et al. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer. PLoS ONE 2016, 11, e0163523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Song, W.; Tian, C.; Wang, K.; Zhang, R.J.; Zou, S.B. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis. PLoS ONE 2017, 12, e0178762. [Google Scholar] [CrossRef] [Green Version]
- Wu, L.; Zou, S.; Wang, C.; Tan, X.; Yu, M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China. BMC Cardiovasc. Disord. 2019, 19, 125. [Google Scholar] [CrossRef] [Green Version]
- Forget, P.; Khalifa, C.; Defour, J.P.; Latinne, D.; Van Pel, M.C.; De Kock, M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res. Notes 2017, 10, 12. [Google Scholar] [CrossRef] [Green Version]
- Azab, B.; Camacho-Rivera, M.; Taioli, E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS ONE 2014, 9, e112361. [Google Scholar] [CrossRef] [Green Version]
- Gumus, F.; Solak, I.; Eryilmaz, M.A. The effects of smoking on neutrophil/lymphocyte, platelet/ /lymphocyte ratios. Bratisl. Lek. Listy. 2018, 119, 116–119. [Google Scholar] [CrossRef]
- Pujani, M.; Chauhan, V.; Singh, K.; Rastogi, S.; Agarwal, C.; Gera, K. The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio. Hematol. Transfus Cell Ther. 2021, 43, 424–429. [Google Scholar] [CrossRef] [PubMed]
- Ahluwalia, N.; Dwyer, J.; Terry, A.; Moshfegh, A.; Johnson, C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv. Nutr. 2016, 7, 121–134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, C.; Arevalo, Y.A.; Nanavati, H.D.; Lin, D.M. Racial differences and an increased systemic inflammatory response are seen in patients with COVID-19 and ischemic stroke. Brain Behav. Immun. Health 2020, 8, 100137. [Google Scholar] [CrossRef] [PubMed]
- Sarkar, S.; Kannan, S.; Khanna, P.; Singh, A.K. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J. Med. Virol. 2022, 94, 211–221. [Google Scholar] [CrossRef] [PubMed]
- Torres, J.M.; Epel, E.S.; To, T.M.; Lee, A.; Aiello, A.E.; Haan, M.N. Cross-border ties, nativity, and inflammatory markers in a population-based prospective study of Latino adults. Soc. Sci. Med. 2018, 211, 21–30. [Google Scholar] [CrossRef] [PubMed]
- Scholaske, L.; Wadhwa, P.D.; Entringer, S. Acculturation and biological stress markers: A systematic review. Psychoneuroendocrinology 2021, 132, 105349. [Google Scholar] [CrossRef]
- Xie, X.; Fu, X.; Zhang, Y.; Huang, W.; Huang, L.; Deng, Y.; Yan, D.; Yao, R. U-shaped relationship between platelet-lymphocyte ratio and postoperative in-hospital mortality in patients with type A acute aortic dissection. BMC Cardiovasc. Disord. 2021, 21, 569. [Google Scholar] [CrossRef]
- Shen, Y.; Huang, X.; Zhang, W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: Interaction effect with disease severity-a retrospective study. BMJ Open 2019, 9, e022896. [Google Scholar] [CrossRef]
- Zhai, G.; Wang, J.; Liu, Y.; Zhou, Y. Platelet-lymphocyte ratio as a new predictor of in-hospital mortality in cardiac intensive care unit patients. Sci. Rep. 2021, 11, 23578. [Google Scholar] [CrossRef]
- Kumar, P.; Law, S.; Sriram, K.B. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. J. Thorac. Dis. 2017, 9, 1509–1516. [Google Scholar] [CrossRef]
- Howard, R.; Scheiner, A.; Kanetsky, P.A.; Egan, K.M. Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratio. Ann. Epidemiol. 2019, 38, 11–21. [Google Scholar] [CrossRef] [PubMed]
- Hsieh, M.; Chin, K.; Link, B.; Stroncek, D.; Wang, E.; Everhart, J.; Tisdale, J.F.; Rodgers, G. Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling. Blood 2005, 106, 3069. [Google Scholar] [CrossRef]
- Castelo-Branco, C.; Soveral, I. The immune system and aging: A review. Gynecol. Endocrinol. 2014, 30, 16–22. [Google Scholar] [CrossRef] [PubMed]
- Tulgar, Y.K.; Cakar, S.; Tulgar, S.; Dalkilic, O.; Cakiroglu, B.; Uyanik, B.S. The effect of smoking on neutrophil/lymphocyte and platelet/lymphocyte ratio and platelet indices: A retrospective study. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 3112–3118. [Google Scholar]
- Ghahremanfard, F.; Semnani, V.; Ghorbani, R.; Malek, F.; Behzadfar, A.; Zahmatkesh, M. Effects of cigarette smoking on morphological features of platelets in healthy men. Saudi Med. J. 2015, 36, 847–850. [Google Scholar] [CrossRef]
- Lee, J.; Taneja, V.; Vassallo, R. Cigarette smoking and inflammation: Cellular and molecular mechanisms. J. Dent. Res. 2012, 91, 142–149. [Google Scholar] [CrossRef]
Characteristics of Interest ¹ | Unweighted Sample | Weighted Population | |
---|---|---|---|
Race | Non-Hispanic White | 6177 (36.7) | 62.46 (58.54–66.22) |
Non-Hispanic Black | 3493 (20.7) | 11.65 (9.949–13.6) | |
Hispanic | 4615 (27.4) | 16.7 (13.99–19.8) | |
Other | 2564 (15.2) | 9.2 (8.01–10.53) | |
Sex | Male | 8550 (50.7) | 50.47 (49.86–51.26) |
Female | 8299 (49.3) | 49.53 (48.74–50.32) | |
Age (years) | 20–29 | 3822 (22.7) | 24.63 (23.1–26.23) |
30–59 | 9366 (55.6) | 58.86 (57.41–60.29) | |
60–79 | 3025 (18.0) | 14.02 (13.15–14.94) | |
80+ | 636 (3.8) | 2.49 (2.2–2.8) | |
Education | <High School | 3902 (23.2) | 15.62 (14.1–17.27) |
High School/General Educational Development | 3636 (21.6) | 20.81 (19.62–22.06) | |
Some College, or Associate of Arts | 4997 (29.7) | 31.72 (30.29–33.18) | |
>College Graduate | 4291 (25.5) | 31.85 (29.52–34.28) | |
Nativity | United States born | 11,042 (65.5) | 78.83 (76.49–80.99) |
Non-United States born | 5797 (34.4) | 21.17 (19.01–23.51) | |
Body mass index (Kg/m2) | Underweight (<18.5) | 291 (1.7) | 1.791(1.527–2.098) |
Normal weight (18.5–24.9) | 4999 (29.7) | 31.43 (29.89–33.01) | |
Overweight (25.0–29.9) | 5369 (31.9) | 33.75 (32.68–34.83) | |
Obese (>30) | 5404 (32.1) | 33.03 (31.7–34.39) | |
Smoking status | Non-smoker | 10,107 (60.0) | 59.63 (58.06–61.18) |
Current smoker | 3454 (20.5) | 19.74 (18.73–20.78) | |
Former smoker | 3272 (19.4) | 20.63 (19.36–21.96) | |
Alcohol usage | Non-drinker | 2133 (12.7) | 11.61 (10.29–13.07) |
Moderate drinker | 4807 (28.5) | 32.83 (31.5–34.19) | |
Heavy drinker | 7406 (44.0) | 55.56 (54.14–56.97) | |
Lymphocytes (1000 cells/µL) | 2.17 (2.15–2.19) | 2.14 (2.11–2.16) | |
Monocytes (1000 cells/µL) | 0.55 (0.54–0.55) | 0.56 (0.55–0.56) | |
Segmented neutrophils (1000 cells/µL) | 4.23 (4.2–4.27) | 4.28 (4.23–4.34) | |
Eosinophils (1000 cells/µL) | 0.2 (0.2–0.2) | 0.20 (0.19–0.20) | |
Basophils number (1000 cells/µL) | 0.05 (0.04–0.05) | 0.05 (0.04–0.05) | |
Platelet count (1000 cells/µL) | 239.46 (238.45–240.47) | 238.89 (237.26–240.53) | |
Neutrophil/lymphocyte ratio (NLR) | 2.12 (2.10–2.14) | 2.16 (2.13–2.19) | |
Platelet/lymphocyte ratio (PLR) | 120.19 (119.48–120.91) | 121.31 (120.01–122.61) |
Sociodemographic Characteristics 2 | Lymphocytes (1000 Cells/µL) | Monocytes (1000 Cells/µL) | Segmented Neutrophils (1000 Cells/µL) | |
---|---|---|---|---|
Race | Non-Hispanic White | 2.09 (2.05–2.12) | 0.57 (0.56–0.58) | 4.37 (4.30–4.44) |
Non-Hispanic Black | 2.24 (2.20–2.27) | 0.52 (0.51–0.53) | 3.66 (3.58–3.74) | |
Hispanic | 2.26 (2.20–2.29) | 0.55 (0.54–0.56) | 4.44 (4.36–4.53) | |
Other | 2.15 (2.12–2.19) | 0.52 (0.51–0.53) | 4.13 (4.03–4.23) | |
Sex | Male | 2.09 (2.06–2.13) | 0.58 (0.57–0.59) | 3.95 (3.92–3.97) |
Female | 2.18 (2.16–2.21) | 0.54 (0.54–0.55) | 4.11 (4.08–4.14) | |
Age (years) | 20–29 | 2.27 (2.23–2.30) | 0.56 (0.55–0.57) | 4.38 (4.28–4.47) |
30–59 | 2.14 (2.11–2.17) | 0.55 (0.54–0.55) | 4.27 (4.22–4.33) | |
60–79 | 1.94 (1.90–1.99) | 0.57 (0.55–0.59) | 4.13 (4.04–4.21) | |
80+ | 1.94 (1.69–2.19) | 0.62 (0.60–0.64) | 4.36 (4.17–4.55) | |
Education | <High School | 2.23 (2.20–2.27) | 0.56 (0.55–0.58) | 4.46 (4.36–4.56) |
High School/General Educational Development | 2.20 (2.16–2.25) | 0.57 (0.56–0.59) | 4.45 (4.37–4.52) | |
Some College, or Associate of Arts | 2.17 (2.14–2.20) | 0.56 (0.55–0.58) | 4.35 (4.28–4.43) | |
>College Graduate | 2.02 (1.20–2.05) | 0.53 (0.52–0.54) | 4.01 (3.94–4.09) | |
Nativity | United States born | 2.12 (2.10–2.15) | 0.56 (0.55–0.57) | 4.34 (4.28–4.40) |
Non-United States born | 2.19 (2.17–2.21) | 0.53 (0.52–0.54) | 4.08 (4.01–4.14) | |
Body mass index (Kg/m2) | Underweight (<18.5) | 2.09 (1.99–2.19) | 0.52 (0.49–0.54) | 4.06 (3.77–4.33) |
Normal weight (18.5–24.9) | 2.01 (1.99–2.02) | 0.53 (0.52–0.53) | 3.40 (3.92–3.07) | |
Overweight (25.0–29.9) | 2.12 (2.08–2.15) | 0.56 (0.55–0.56) | 4.18 (4.10–4.25) | |
Obese (>30) | 2.28 (2.25–2.31) | 0.58 (0.57–0.59) | 4.66 (4.59–4.72) | |
Smoking status | Non-smoker | 2.09 (2.07–2.11) | 0.54 (0.53–0.54) | 4.09 (4.04–4.15) |
Current smoker | 2.36 (2.32–2.42) | 0.60 (0.59–0.60) | 4.87 (4.77–4.97) | |
Former smoker | 2.04 (2.01–2.07) | 0.57 (0.56–0.57) | 4.26 (4.17–4.36) | |
Alcohol usage | Non-drinker | 2.16 (2.10–2.22) | 0.54 (0.53–0.56) | 4.17 (4.07–4.27) |
Moderate drinker | 2.08 (2.04–2.12) | 0.54 (0.53–0.55) | 4.19 (4.12–4.27) | |
Heavy drinker | 2.16 (2.13–2.18) | 0.57 (0.56–0.58) | 4.34 (4.28–4.41) | |
Sociodemographic Characteristics | Eosinophils (1000 Cells/µL) | Basophils (1000 Cells/µL) | Platelet/Lymphocyte Ratio | |
Race | Non-Hispanic White | 0.20 (0.19–0.20) | 0.05 (0.45–0.05) | 123.12 (121.13–125.11) |
Non-Hispanic Black | 0.18 (0.17–0.19) | 0.04 (0.04–0.05) | 119.77 (117.49–122.06) | |
Hispanic | 0.20 (0.20–0.21) | 0.04 (0.04–0.05) | 116.33 (114.69–117.97) | |
Other | 0.21 (0.20–0.22) | 0.04 (0.04–0.05) | 119.84 (116.88–122.81) | |
Sex | Male | 0.24 (0.24–0.24) | 0.04 (0.04–0.05) | 117.75 (116.25–119.26) |
Female | 0.20 (0.20–0.20) | 0.04 (0.04–0.05) | 124.94 (123.28–126.61) | |
Age (years) | 20–29 | 0.19 (0.19–0.20) | 0.04 (0.04–0.05) | 114.92 (113.02–116.83) |
30–59 | 0.19 (0.19–0.20) | 0.05 (0.04–0.05) | 121.67 (120.17–123.18) | |
60–79 | 0.21 (0.20–0.22) | 0.05 (0.05–0.05) | 128.62 (125.83–131.42) | |
80+ | 0.22 (0.20–0.23) | 0.05 (0.04–0.05) | 133.78 (127.83–139.73) | |
Education | <High School | 0.21 (0.20–0.22) | 0.05 (0.04–0.05) | 115.05 (112.75–117.35) |
High School/General Educational Development | 0.20 (0.19–0.21) | 0.05 (0.05–0.05) | 118.93 (116.61–121.24) | |
Some College, or Associate of Arts | 0.19 (0.19–0.20) | 0.05 (0.05–0.05) | 121.08 (119.24–122.91) | |
>College Graduate | 0.18 (0.18–0.19) | 0.04 (0.04–0.04) | 126.11 (124.03–128.19) | |
Nativity | United States born | 0.19 (0.19–0.20) | 0.05 (0.05–0.05) | 122.78 (121.22–124.33) |
Non-United States born | 0.20 (0.20–0.21) | 0.04 (0.04–0.04) | 115.85 (114.17–117.52) | |
Body mass index (Kg/m2) | Underweight (<18.5) | 0.17 (0.15–0.19) | 0.05 (0.04–0.06) | 124.61 (118.82–130.40) |
Normal weight (18.5–24.9) | 0.18 (0.17–0.18) | 0.04 (0.04–0.04) | 125.01 (122.93–127.09) | |
Overweight (25.0–29.9) | 0.20 (0.19–0.20) | 0.04 (0.04–0.05) | 120.21 (118.34–122.08) | |
Obese (>30) | 0.21 (0.21–0.22) | 0.05 (0.05–0.05) | 118.56 (116.79–120.32) | |
Smoking status | Non-smoker | 0.18 (0.18–0.19) | 0.04 (0.04–0.04) | 123.51 (122.08–124.94) |
Current smoker | 0.22 (0.22–0.23) | 0.06 (0.05–0.06) | 111.02 (108.89–113.16) | |
Former smoker | 0.20 (0.20–0.21) | 0.05 (0.04–0.05) | 124.77 (122.55–127.00 | |
Alcohol usage | Non-drinker | 0.19 (0.18–0.20) | 0.04 (0.38–0.05) | 122.41 (119.53–125.29) |
Moderate drinker | 0.19 (0.18–0.20) | 0.04 (0.04–0.05) | 124.21 (122.17–126.25) | |
Heavy drinker | 0.20 (0.20–0.21) | 0.05 (0.05–0.05) | 119.87 (118.14–121.60) | |
Sociodemographic Characteristics | Platelet Count (1000 Cells/µL) | Neutrophil/Lymphocyte Ratio | ||
Race | Non-Hispanic White | 235.64 (233.72–237.56) | 2.27 (2.22–2.31) | |
Non-Hispanic Black | 243.92 (240.75–247.09) | 1.78 (1.74–1.83) | ||
Hispanic | 245.18 (242.85–247.50) | 2.10 (2.04–2.16) | ||
Other | 240.52 (236.65–244.39) | 2.03 (1.98–2.08) | ||
Sex | Male | 243.37 (242.34–244.40) | 2.19 (2.15–2.23) | |
Female | 263.52 (262.50–264.54) | 2.14 (2.10–2.17) | ||
Age (years) | 20–29 | 242.92 (240.37–245.46) | 2.06 (2.01–2.11) | |
30–59 | 240.68 (238.76–242.60) | 2.13 (2.1–2.17) | ||
60–79 | 227.22 (223.46–230.98) | 2.35 (2.29–2.41) | ||
80+ | 211.45 (206.22–216.68) | 2.81 (2.64–2.97) | ||
Education | <High School | 238.89 (235.65–242.13) | 2.16 (2.09–2.22) | |
High School/General Educational Development | 239.56 (236.47–242.65) | 2.19 (2.14–2.24) | ||
Some College, or Associate of Arts | 241.24 (239.15–243.33) | 2.17 (2.12–2.21) | ||
>College Graduate | 235.18 (232.56–237.81) | 2.15 (2.09–2.20) | ||
Nativity | United States born | 239.20 (237.44–240.94) | 2.21 (2.17–2.25) | |
Non-United States born | 236.40 (233.73–239.07) | 1.98 (1.95–2.02) | ||
Body mass index (Kg/m2) | Underweight (<18.5) | 237.38 (227.95–246.81) | 2.13 (1.95–2.31) | |
Normal weight (18.5–24.9) | 232.19 (230.01–234.37) | 2.14 (2.09–2.20) | ||
Overweight (25.0–29.9) | 233.71 (231.61–235.80) | 2.14 (2.10–2.18) | ||
Obese (>30) | 249.83 (247.43–252.24) | 2.19 (2.15–2.23) | ||
Smoking status | Non-smoker | 239.27 (237.45–241.08) | 2.1 (2.07–2.13) | |
Current smoker | 241.36 (238.94–243.78) | 2.22 (2.17–2.28) | ||
Former smoker | 234.08 (231.28–236.87) | 2.28 (2.23–2.34) | ||
Alcohol usage | Non-drinker | 242.17 (238.08–246.26) | 2.1 (2.03–2.15) | |
Moderate drinker | 237.01 (234.20–239.81) | 2.2 (2.15–2.25) | ||
Heavy drinker | 238.37 (236.25–240.5) | 2.17 (2.13–2.20) |
Sociodemographic Characteristics | Lymphocytes (1000 Cells/µL) | Monocytes (1000 Cells/µL) | Segmented Neutrophils (1000 Cells/µL) | |
---|---|---|---|---|
Estimate (95% CI) | Estimate (95% CI) | Estimate (95% CI) | ||
Race | Non-Hispanic White | REF | REF | REF |
Non-Hispanic Black | 0.058 (0.014–0.102) * | −0.055 (−0.066–−0.044) *** | −0.852 (−0.960–−0.745) *** | |
Hispanic | 0.0683 (0.017–0.120) * | −0.012 (−0.027–−0.002) | 0.080 (−0.051–0.213) | |
Other | 0.060 (−0.005–0.125) | −0.023 (−0.039–−0.007) ** | 0.053 (−0.084–0.190) | |
Sex | Male | REF | REF | REF |
Female | 0.116 (0.080–0.153) *** | −0.047 (−0.056–−0.037) *** | 0.053 (0.165–0.318) *** | |
Age (years) | 20–29 | REF | REF | REF |
30–59 | −0.145 (−0.188–−0.103) * | −0.016 (−0.028–−0.005) ** | −0.123 (−0.211–−0.344) ** | |
60–79 | −0.312 (−0.370–−0.253) * | 0.002 (−0.018–0.023) | −0.252 (−0.353–−0.150) *** | |
80+ | −0.228 (−0.514–0.058) | 0.062 (0.370–0.087) *** | 0.062 (−0.157–0.281) | |
Education | <High School | REF | REF | REF |
High School/General Educational Development | 0.002 (−0.046–0.050) | 0.001 (−0.141–0.016) | −0.816 (−0.203–0.040) | |
Some College, or Associate of Arts | −0.242 (−0.783–0.030) | 0.001 (−0.012–0.140) | −0.159 (−0.289–−0.029) * | |
>College Graduate | −0.095 (−0.147–−0.043) *** | −0.027 (−0.038–−0.007) ** | −0.331 (−0.454–−0.209) *** | |
Nativity | United States born | REF | REF | REF |
Non-United States born | 0.063 (0.023–0.104) ** | −0.016 (−0.029–−0.003) ** | −0.234 (−0.341–−0.127) *** | |
Body mass index (Kg/m2) | Underweight (<18.5) | −0.012 (−0.117–0.093) | −0.004 (−0.029–0.021) | −0.034 (−0.334–0.267) |
Normal weight (18.5–24.9) | REF | REF | REF | |
Overweight (25.0–29.9) | 0.139 (0.096–0181) *** | 0.025 (0.015–0.034) *** | 0.237 (0.145–0.329) *** | |
Obese (>30) | 0.286 (0.241–0.330) *** | 0.055 (0.044–0.066) *** | 0.720 (0.632–0.809) *** | |
Smoking status | Non-smoker | REF | REF | REF |
Current smoker | 0.282 (0.231–0.333) *** | 0.054 (0.043–0.065) *** | 0.756 (0.662–0.850) *** | |
Former smoker | 0.005 (−0.038–0.049) | 0.016 (0.003–0.029) ** | 0.100 (0.008–0.191) * | |
Alcohol usage | Non-drinker | REF | REF | REF |
Moderate drinker | −0.011 (−0.093–0.070) | −0.015 (−0.031–0.001) | 0.025 (−0.075–0.013) | |
Heavy drinker | −0.200 (−0.091–0.051) | −0.003 (−0.17–0.012) | 0.015 (−0.072–0.103) | |
Sociodemographic Characteristics | Eosinophils (1000 Cells/µL) | Basophils (1000 Cells/µL) | ||
Estimate (95% CI) | Estimate (95% CI) | |||
Race | Non-Hispanic White | REF | REF | |
Non-Hispanic Black | −0.018 (−0.027–−0.010) *** | −0.005 (−0.009–−0.002) ** | ||
Hispanic | −0.003 (−0.0130–0.007) | −0.002 (−0.007–0.002) | ||
Other | 0.016 (0.002–0.030) * | −0.001 (−0.005–0.004) | ||
Sex | Male | REF | REF | |
Female | −0.020 (−0.028–−0.012) *** | 0.002 (−0.001–0.005) | ||
Age (years) | 20–29 | REF | REF | |
30–59 | −0.001 (−0.010–0.008) | 0.004 (0.001–0.006) * | ||
60–79 | 0.011 (−0.002–0.024) | 0.007 (0.002–0.011) ** | ||
80+ | 0.032 (0.012–0.053) ** | 0.010 (0.003–0.017) ** | ||
Education | <High School | REF | REF | |
High School/General Educational Development | −0.007 (−0.021–0.007) | −0.001 (−0.004–0.003) | ||
Some College, or Associate of Arts | −0.009 (−0.020–0.003) | −0.001 (−0.005–0.003) | ||
>College Graduate | −0.011 (−0.023–0.001) | −0.002 (−0.005–0.001) * | ||
Nativity | United States born | REF | REF | |
Non-United States born | 0.010 (0.001–0.020) ** | −0.002 (−0.005–0.001) | ||
Body mass index (Kg/m2) | Underweight (<18.5) | −0.003 (−0.027–0.020) | 0.003 (−0.006–0.127) | |
Normal weight (18.5–24.9) | REF | REF | ||
Overweight (25.0–29.9) | 0.018 (0.009–0.027) *** | 0.003 (−0.001–0.006) | ||
Obese (>30) | 0.036 (0.027–0.046) *** | 0.011 (0.008–0.015) *** | ||
Smoking status | Non-smoker | REF | REF | |
Current smoker | 0.039 (0.029–0.049) *** | 0.034 (0.010–0.018) *** | ||
Former smoker | 0.012 (0.001–0.022) * | 0.002 (−0.002–0.005) | ||
Alcohol usage | Non-drinker | REF | REF | |
Moderate drinker | −0.002 (−0.013–0.009) | 0.002 (−0.003–0.006) | ||
Heavy drinker | 0.030 (−0.008–0.014) | 0.004 (−0.001–0.009) | ||
Sociodemographic Characteristics | Platelet Count | Neutrophil/Lymphocyte Ratio | ||
Estimate (95% CI) | Estimate (95% CI) | |||
Race | Non-Hispanic White | REF | REF | |
Non-Hispanic Black | 3.404 (−0.383–7.190) | −0.445 (−0.517–−0.372) *** | ||
Hispanic | 10.682 (7.000–14.370) *** | −0.030 (−0.0136–0.076) | ||
Other | 11.102 (5.512–16.690) *** | −0.0653 (−0.0156–0.025) | ||
Sex | Male | REF | REF | |
Female | 27.174 (25.060–29.289) *** | −0.029 (−0.074–0.0153) | ||
Age (years) | 20–29 | REF | REF | |
30–59 | −2.709 (−3.215–4.968) | 0.090 (0.031–0.150) ** | ||
60–79 | −15.183 (−19.935–−10.429) *** | 0.278 (0.204–0.351) *** | ||
80+ | −25.420 (−31.748–−19.094) *** | 0.707 (−0.162–0.038) *** | ||
Education | <High School | REF | REF | |
High School/General Educational Development | 0.876 (−3.215–4.968) | −0.034 (−0.0121–0.052) | ||
Some College, or Associate of Arts | −0.157 (−4.287–3.972) | −0.0470 (−0.0133–0.049) | ||
>College Graduate | −2.177 (−6.894–2.540) | −0.062 (−0.016–0.038) | ||
Nativity | United States born | REF | REF | |
Non-United States born | −7.830 (−11.931–−3.729) *** | −0.186 (−0.258–−0.113) *** | ||
Body mass index (Kg/m2) | Underweight (<18.5) | −2.310 (−12.510–7.888) | −0.0262 (−0.0232–0.179) | |
Normal weight (18.5–24.9) | REF | REF | ||
Overweight (25.0–29.9) | 5.643 (2.840–8.446) *** | −0.110 (−0.171–−0.049) *** | ||
Obese (>30) | 18.059 (14.911–21.207) *** | −0.034 (−0.099–0.031) | ||
Smoking status | Non-smoker | REF | REF | |
Current smoker | 3.908 (0.739–7.077) * | 0.11 (0.05–0.171) *** | ||
Former smoker | 0.600 (−2.494–3.634) | 0.076 (0.018–134) * | ||
Alcohol usage | Non-drinker | REF | REF | |
Moderate drinker | −1.433 (−6.490–3.624) | 2.27 (2.038–2.508) *** | ||
Heavy drinker | 0.847 (−3.783–5.477) *** |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Calixte, R.; Ye, Z.; Haq, R.; Aladhamy, S.; Camacho-Rivera, M. Demographic and Social Patterns of the Mean Values of Inflammatory Markers in U.S. Adults: A 2009–2016 NHANES Analysis. Diseases 2023, 11, 14. https://doi.org/10.3390/diseases11010014
Calixte R, Ye Z, Haq R, Aladhamy S, Camacho-Rivera M. Demographic and Social Patterns of the Mean Values of Inflammatory Markers in U.S. Adults: A 2009–2016 NHANES Analysis. Diseases. 2023; 11(1):14. https://doi.org/10.3390/diseases11010014
Chicago/Turabian StyleCalixte, Rose, Zachary Ye, Raisa Haq, Salwa Aladhamy, and Marlene Camacho-Rivera. 2023. "Demographic and Social Patterns of the Mean Values of Inflammatory Markers in U.S. Adults: A 2009–2016 NHANES Analysis" Diseases 11, no. 1: 14. https://doi.org/10.3390/diseases11010014
APA StyleCalixte, R., Ye, Z., Haq, R., Aladhamy, S., & Camacho-Rivera, M. (2023). Demographic and Social Patterns of the Mean Values of Inflammatory Markers in U.S. Adults: A 2009–2016 NHANES Analysis. Diseases, 11(1), 14. https://doi.org/10.3390/diseases11010014